Who Owns LYELL IMMUNOPHARMA INC (LYEL)? -- Institutional Holders (2026-06-30)
96 institutions reported holding $180.5M of LYELL IMMUNOPHARMA INC (LYEL) in SEC 13F filings for 2026-06-30. Largest institutional holders: ARCH Venture Management, LLC ($45.5M), GSK plc ($21.3M), VANGUARD GROUP INC ($13.7M), Orland Properties Ltd ($10.6M), BlackRock, Inc. ($10.2M). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|
| 1 | ARCH Venture Management, LLC | $45.5M | 3.2M | Hold |
| 2 | GSK plc | $21.3M | 1.5M | Hold |
| 3 | VANGUARD GROUP INC | $13.7M | 976,925 | Added |
| 4 | Orland Properties Ltd | $10.6M | 754,698 | Hold |
| 5 | BlackRock, Inc. | $10.2M | 724,342 | Added |
| 6 | Decheng Capital LLC | $9.7M | 692,050 | Hold |
| 7 | Almitas Capital LLC | $8.2M | 581,407 | Added |
| 8 | Foresite Capital Management V, LLC | $6.7M | 476,386 | Trimmed |
| 9 | MILLENNIUM MANAGEMENT LLC | $5.2M | 367,473 | Trimmed |
| 10 | Opaleye Management Inc. | $4.8M | 344,025 | Added |
| 11 | venBio Partners LLC | $4.7M | 337,697 | Hold |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $4.4M | 310,636 | Added |
| 13 | Alphabet Inc. | $4.1M | 293,256 | Hold |
| 14 | STATE STREET CORP | $2.6M | 185,322 | Added |
| 15 | HSG Holding Ltd | $2.1M | 152,299 | Hold |
| 16 | RENAISSANCE TECHNOLOGIES LLC | $1.8M | 130,190 | Added |
| 17 | NORTHERN TRUST CORP | $1.7M | 118,500 | Added |
| 18 | Qube Research & Technologies Ltd | $1.6M | 110,531 | Added |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.5M | 107,570 | Added |
| 20 | Sixth Street Partners Management Company, L.P. | $1.5M | 107,570 | New |
| 21 | MARSHALL WACE, LLP | $1.5M | 106,300 | Trimmed |
| 22 | Velan Capital Investment Management LP | $1.5M | 105,000 | Added |
| 23 | MIC Capital Management UK LLP | $1.2M | 87,028 | Hold |
| 24 | GOLDMAN SACHS GROUP INC | $1.2M | 86,779 | Trimmed |
| 25 | DIMENSIONAL FUND ADVISORS LP | $957,066 | 68,315 | Added |
Source: SEC Form 13F filings · as of 2026-06-30